MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
出版年份 2012 全文链接
标题
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 10, Pages 1563-1573
出版商
Informa Healthcare
发表日期
2012-07-16
DOI
10.1517/13543784.2012.707192
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, in patients (pts) with advanced solid tumors: Phase I study of multiple treatment schedules.
- (2017) J. S. Kauh et al. JOURNAL OF CLINICAL ONCOLOGY
- Ubiquitin-Binding Proteins: Decoders of Ubiquitin-Mediated Cellular Functions
- (2012) Koraljka Husnjak et al. Annual Review of Biochemistry
- Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924
- (2012) Michael A. Milhollen et al. CANCER CELL
- Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents
- (2012) Y. Kee et al. MOLECULAR CANCER RESEARCH
- Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma
- (2012) D. W. McMillin et al. MOLECULAR CANCER THERAPEUTICS
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
- (2012) Dong Yang et al. PLoS One
- A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
- (2012) Julia I. Toth et al. Cell Reports
- Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
- (2011) D. Wei et al. CANCER RESEARCH
- Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover
- (2011) M. A. Milhollen et al. CANCER RESEARCH
- TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers
- (2011) K. Noguchi et al. CARCINOGENESIS
- Treatment Options for Relapsed and Refractory Multiple Myeloma
- (2011) Sagar Lonial et al. CLINICAL CANCER RESEARCH
- Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
- (2011) Amy M. Ruschak et al. JNCI-Journal of the National Cancer Institute
- Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program
- (2011) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
- (2010) R. T. Swords et al. BLOOD
- NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
- (2010) J. J. Lin et al. CANCER RESEARCH
- Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
- (2010) James E. Brownell et al. MOLECULAR CELL
- Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
- (2009) Jacob P. Laubach et al. LEUKEMIA & LYMPHOMA
- E2-RING Expansion of the NEDD8 Cascade Confers Specificity to Cullin Modification
- (2009) Danny T. Huang et al. MOLECULAR CELL
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Origin and function of ubiquitin-like proteins
- (2009) Mark Hochstrasser NATURE
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
- (2009) Brenda A. Schulman et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
- (2008) Alan L. Schwartz et al. Annual Review of Pharmacology and Toxicology
- The ubiquitin system, disease, and drug discovery
- (2008) Matthew D Petroski BMC BIOCHEMISTRY
- Structural Insights into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of Conjugation
- (2008) David M. Duda et al. CELL
- Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade
- (2008) R. Z. Orlowski et al. CLINICAL CANCER RESEARCH
- Bortezomib in the front-line treatment of multiple myeloma
- (2008) Paul G Richardson et al. Expert Review of Anticancer Therapy
- SCCRO (DCUN1D1) Is an Essential Component of the E3 Complex for Neddylation
- (2008) Alexander Y. Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Targeted Proteomic Analysis of the Ubiquitin-Like Modifier Nedd8 and Associated Proteins
- (2008) Jeffrey Jones et al. JOURNAL OF PROTEOME RESEARCH
- Dcn1 Functions as a Scaffold-Type E3 Ligase for Cullin Neddylation
- (2008) Thimo Kurz et al. MOLECULAR CELL
- Multimodal Activation of the Ubiquitin Ligase SCF by Nedd8 Conjugation
- (2008) Anjanabha Saha et al. MOLECULAR CELL
- Diversity of degradation signals in the ubiquitin–proteasome system
- (2008) Tommer Ravid et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started